Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
25%
Ph phase_2
2
25%
Ph phase_3
1
13%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(2)
Other(3)

Detailed Status

unknown3
Completed2
Recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (40.0%)
Phase 31 (20.0%)
N/A2 (40.0%)

Trials by Status

unknown338%
not_yet_recruiting113%
completed225%
recruiting225%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
OTHER
Total Trials
8